Detalhe da pesquisa
1.
Five-Year Oncologic Outcome and Surgical Completeness of Transoral Robotic Thyroidectomy for Papillary Thyroid Carcinoma: Comparison with Conventional Transcervical Thyroidectomy Using Propensity Score Matching.
Ann Surg Oncol
; 30(4): 2256-2264, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36602660
2.
A Fully-Human Antibody Specifically Targeting a Membrane-Bound Fragment of CADM1 Potentiates the T Cell-Mediated Death of Human Small-Cell Lung Cancer Cells.
Int J Mol Sci
; 23(13)2022 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35805896
3.
Risk factors for hypothyroidism and thyroid hormone replacement after hemithyroidectomy in papillary thyroid carcinoma.
Langenbecks Arch Surg
; 406(4): 1223-1231, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33970335
4.
ASO Visual Abstract: Five-Year Oncologic Outcome and Surgical Completeness of Transoral Robotic Thyroidectomy for Papillary Thyroid Carcinoma: Comparison with Conventional Transcervical Thyroidectomy Using Propensity Score-Matching.
Ann Surg Oncol
; 30(4): 2265, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36635523
5.
Glycan structure and serum half-life of recombinant CTLA4Ig, an immunosuppressive agent, expressed in suspension-cultured rice cells with coexpression of human ß1,4-galactosyltransferase and human CTLA4Ig.
Glycoconj J
; 32(3-4): 161-72, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25971702
6.
Chimeric Antigen Receptor T Cells With Modified Interleukin-13 Preferentially Recognize IL13Rα2 and Suppress Malignant Glioma: A Preclinical Study.
Front Immunol
; 12: 715000, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34819930
7.
First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients.
Ther Adv Med Oncol
; 12: 1758835920926796, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32536979
8.
Production and characterization of long-acting recombinant human albumin-EPO fusion protein expressed in CHO cell.
Protein Expr Purif
; 68(2): 137-45, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19595770
9.
Humanized Anti-hepatocyte Growth Factor Monoclonal Antibody (YYB-101) Inhibits Ovarian Cancer Progression.
Front Oncol
; 9: 571, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31355133
10.
Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma.
Neuro Oncol
; 21(2): 222-233, 2019 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29939324
11.
Preclinical development of a humanized neutralizing antibody targeting HGF.
Exp Mol Med
; 49(3): e309, 2017 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28336956
12.
Characterization of human cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (hCTLA4Ig) expressed in transgenic rice cell suspension cultures.
Biotechnol Lett
; 28(24): 2039-48, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17072529
13.
Rapid establishment of CHO cell lines producing the anti-hepatocyte growth factor antibody SFN68.
J Microbiol Biotechnol
; 23(8): 1176-84, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23727793
14.
Inhibition of tumor growth in a mouse xenograft model by the humanized anti-HGF monoclonal antibody YYB-101 produced in a large-scale CHO cell culture.
J Microbiol Biotechnol
; 23(9): 1327-38, 2013 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-23851271
15.
Production and characterization of human CTLA4Ig expressed in transgenic rice cell suspension cultures.
Protein Expr Purif
; 51(2): 293-302, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17079164